BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4320455)

  • 1. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
    Kukovetz WR; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):189-94. PubMed ID: 4320455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition by Intensain of phosphodiesterease from rat hearts].
    Nitz RE; Schraven E; Trottnow D
    Experientia; 1968 Apr; 24(4):334-5. PubMed ID: 4303108
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis.
    Beavo JA; Rogers NL; Crofford OB; Baird CE; Hardman JG; Sutherland EW; Newman EV
    Ann N Y Acad Sci; 1971 Dec; 185():129-36. PubMed ID: 4330487
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
    Pöch G; Kukovetz WR
    Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation.
    Lugnier C; Bertrand Y; Stoclet JC
    Eur J Pharmacol; 1972 Jul; 19(1):134-6. PubMed ID: 4340226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of coronary-active substances on the uptake of adenosine in the isolated, beating heart].
    Volkmer I; Pfleger K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):155-6. PubMed ID: 4979632
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase.
    Schwabe U; Berndt S; Ebert R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):62-74. PubMed ID: 4338396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of diuretics on 3',5'-AMP-phosphodiesterase].
    Schultz G; Senft G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):61-2. PubMed ID: 4297756
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nucleotides and a nondialyzable factor on the hydrolysis of cyclic AMP by a cyclic nucleotide phosphodiesterase from beef heart.
    Goren EN; Rosen OM
    Arch Biochem Biophys; 1971 Feb; 142(2):720-3. PubMed ID: 4323731
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition by papaverine of 3',5'-nucleotide-phosphodiesterase (E.C.3.1.4.1.) from bovine uterus muscle.
    Rufeger U; Tellhelm B; Frimmer M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):428-30. PubMed ID: 4328803
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of papaverine on isolated coronary vessels].
    Kukovetz WR; Juan H; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):262-3. PubMed ID: 4310612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of the inhibitory activity of some substituted theophyllines on the phosphodiesterase specific for the adenosine 3'5'-monophosphate].
    Lespagnol A; Debaert M; Mizon J; Mizon-Capron
    Therapie; 1970; 25(4):707-13. PubMed ID: 4318831
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators.
    Kobayashi A; Ogawa K
    Jpn Circ J; 1979 Dec; 43 Suppl 1():6-8, 46-54. PubMed ID: 230369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic phosphodiesterase activity and the action of papaverine.
    Triner L; Vulliemoz Y; Schwartz I; Nahas GG
    Biochem Biophys Res Commun; 1970 Jul; 40(1):64-9. PubMed ID: 4318586
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators.
    Vigdahl RL; Mongin J; Marquis NR
    Biochem Biophys Res Commun; 1971 Mar; 42(6):1088-94. PubMed ID: 4323846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
    Meisel M; Meisel P
    Pharmazie; 1974 Sep; 29(9):361-8. PubMed ID: 4213610
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets.
    Markwardt F; Hoffmann A
    Biochem Pharmacol; 1970 Aug; 19(8):2519-20. PubMed ID: 4329211
    [No Abstract]   [Full Text] [Related]  

  • 19. Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.
    Klotz U; Vapaatalo H; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):376-85. PubMed ID: 4340534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
    Pfleger K; Volkmer I; Kolassa N
    Arzneimittelforschung; 1969 Dec; 19(12):1972-4. PubMed ID: 4985338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.